Zinc Binding to the Tyr402 and His402 Allotypes of Complement Factor H: Possible Implications for Age-Related Macular Degeneration

The Tyr402His polymorphism of complement factor H (FH) with 20 short complement regulator (SCR) domains is associated with age-related macular degeneration (AMD). How FH contributes to disease pathology is not clear. Both FH and high concentrations of zinc are found in drusen deposits, the key feature of AMD. Heterozygous FH is inhibited by zinc, which causes FH to aggregate. Here, zinc binding to homozygous FH was studied. By analytical ultracentrifugation, large amounts of oligomers were observed with both the native Tyr402 and the AMD-risk His402 homozygous allotypes of FH and both the recombinant SCR-6/8 allotypes with Tyr/His402. X-ray scattering also showed that both FH and SCR-6/8 allotypes strongly aggregated at > 10 μM zinc. The SCR-1/5 and SCR-16/20 fragments were less likely to bind zinc. These observations were supported by bioinformatics predictions. Starting from known zinc binding sites in crystal structures, we predicted 202 putative partial surface zinc binding sites in FH, most of which were in SCR-6. Metal site prediction web servers also suggested that SCR-6 and other domains bind zinc. Predicted SCR-6/8 dimer structures showed that zinc binding sites could be formed at the protein–protein interface that would lead to daisy-chained oligomers. It was concluded that zinc binds weakly to FH at multiple surface locations, most probably within the functionally important SCR-6/8 domains, and this explains why zinc inhibits FH activity. Given the high pathophysiological levels of bioavailable zinc present in subretinal deposits, we discuss how zinc binding to FH may contribute to deposit formation and inflammation associated with AMD.

[1]  A. Goldman,et al.  Structure of complement factor H carboxyl‐terminus reveals molecular basis of atypical haemolytic uremic syndrome , 2006, The EMBO journal.

[2]  S. Perkins,et al.  Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. , 2001, Journal of molecular biology.

[3]  P. Roversi,et al.  Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates , 2009, Nature.

[4]  Charles P. Fontaine,et al.  Cytosolic zinc buffering and muffling: their role in intracellular zinc homeostasis. , 2010, Metallomics : integrated biometal science.

[5]  S. Perkins,et al.  Implications of the progressive self-association of wild-type human factor H for complement regulation and disease. , 2008, Journal of molecular biology.

[6]  W. Maret.  The Regulatory and Signaling Functions of Zinc Ions in Human Cellular Physiology , 2010 .

[7]  S. Ranganathan,et al.  A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. , 2000, European Journal of Immunology.

[8]  T. Peto,et al.  Cure or cause: opposing roles for zinc in age-related macular degeneration , 2008 .

[9]  S. Perkins,et al.  Uncontrolled zinc- and copper-induced oligomerisation of the human complement regulator factor H and its possible implications for function and disease. , 2008, Journal of molecular biology.

[10]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[11]  Ruth Nussinov,et al.  PatchDock and SymmDock: servers for rigid and symmetric docking , 2005, Nucleic Acids Res..

[12]  U. Schlötzer-Schrehardt,et al.  Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. , 2007, Molecular immunology.

[13]  A. J. Day,et al.  Inhibitory effect of Zn2+ ions on the degradation of the complement activation fragment C3b , 1986 .

[14]  A C Bird,et al.  Bruch's membrane change with age. , 1992, The British journal of ophthalmology.

[15]  P T de Jong,et al.  An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .

[16]  R. Porter,et al.  Purification of the human complement control protein C3b inactivator. , 1980, The Biochemical journal.

[17]  Rudolfs K. Zalups,et al.  Cellular and Molecular Biology of Metals , 2010 .

[18]  A. Dodds.  Small-scale preparation of complement components C3 and C4. , 1993, Methods in enzymology.

[19]  Robert F Mullins,et al.  A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.

[20]  G. Remuzzi,et al.  The interactive Factor H–atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models , 2007, Human mutation.

[21]  M. Oppermann,et al.  The C‐terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein , 2006, Clinical and experimental immunology.

[22]  V. Emery,et al.  Human complement factor I: its expression by insect cells and its biochemical and structural characterisation. , 1998, Molecular immunology.

[23]  M. Galin,et al.  Ocular zinc concentration. , 1962, Investigative ophthalmology.

[24]  Robert B Sim,et al.  Human Complement Factor I Does Not Require Cofactors for Cleavage of Synthetic Substrates 1 , 2004, The Journal of Immunology.

[25]  J. Ott,et al.  CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. , 2008, Ophthalmology.

[26]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[27]  I. Campbell,et al.  Solution structure of a pair of complement modules by nuclear magnetic resonance. , 1993, Journal of molecular biology.

[28]  Ami Miller,et al.  The His402 allotype of complement factor H show similar self-association to the Tyr402 allotype but exhibits greater self-association in the presence of zinc , 2010 .

[29]  K. Blennow,et al.  Association of complement factor H Y402H gene polymorphism with Alzheimer's disease , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[30]  Robert F. Mullins,et al.  An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.

[31]  K. Kobayashi,et al.  Crystal structure of human serum albumin at 2.5 A resolution. , 1999, Protein engineering.

[32]  S. Perkins,et al.  Multimeric interactions between complement factor H and its C3d ligand provide new insight on complement regulation. , 2009, Journal of molecular biology.

[33]  D. Uhrín,et al.  A New Map of Glycosaminoglycan and C3b Binding Sites on Factor H1 , 2008, The Journal of Immunology.

[34]  T. Peto,et al.  High concentration of zinc in sub-retinal pigment epithelial deposits. , 2007, Experimental eye research.

[35]  G. A. Howell,et al.  Stimulation-induced uptake and release of zinc in hippocampal slices , 1984, Nature.

[36]  David J. Schuller,et al.  Crystal Structure of a Thermophilic Cytochrome P450 from the Archaeon Sulfolobus solfataricus * , 2000, The Journal of Biological Chemistry.

[37]  H. E. Gilbert,et al.  Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin. , 2007, Journal of molecular biology.

[38]  J. Diamond,et al.  Zinc uptake by primate retinal pigment epithelium and choroid. , 1992, Current eye research.

[39]  Yuan Li,et al.  Coordination dynamics of zinc in proteins. , 2009, Chemical reviews.

[40]  Michael F. Marmor,et al.  The Retinal Pigment Epithelium , 2016 .

[41]  S. Wodak,et al.  Assessment of CAPRI predictions in rounds 3–5 shows progress in docking procedures , 2005, Proteins.

[42]  H. E. Gilbert,et al.  The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties. , 2008, Journal of molecular biology.

[43]  H. E. Gilbert,et al.  X-ray and neutron scattering data and their constrained molecular modeling. , 2008, Methods in cell biology.

[44]  Peter J Sadler,et al.  Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. , 2008, Biochemical Society transactions.

[45]  Robert B Sim,et al.  Molecular modelling of human complement component C3 and its fragments by solution scattering. , 1986, European journal of biochemistry.

[46]  The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7. , 2002, The Journal of nutrition.

[47]  M. Pangburn,et al.  Complement control protein factor H: the good, the bad, and the inadequate. , 2010, Molecular immunology.

[48]  Robert B Sim,et al.  Oligomeric domain structure of human complement factor H by X-ray and neutron solution scattering. , 1991, Biochemistry.

[49]  Sergey Lyskov,et al.  The RosettaDock server for local protein–protein docking , 2008, Nucleic Acids Res..

[50]  N. Osborne,et al.  Zinc in the retina , 2001, Progress in Neurobiology.

[51]  D. Soares,et al.  Structural Biology of the Complement System , 2005 .

[52]  O. Glatter,et al.  19 – Small-Angle X-ray Scattering , 1973 .

[53]  Jeffrey J. Gray,et al.  Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations. , 2003, Journal of molecular biology.

[54]  D. Ritchie,et al.  Evaluation of Protein Docking Predictions Using Hex 3.1 in CAPRI Rounds 1{2 , 2002 .

[55]  Dean P. Jones,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. , 2001, Archives of ophthalmology.

[56]  V. Fischetti,et al.  Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[57]  V. Sobolev,et al.  Prediction of transition metal‐binding sites from apo protein structures , 2007, Proteins.

[58]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[59]  Sandor Vajda,et al.  ClusPro: an automated docking and discrimination method for the prediction of protein complexes , 2004, Bioinform..

[60]  J. Lidholm,et al.  BIACORE analysis of histidine-tagged proteins using a chelating NTA sensor chip. , 1997, Analytical biochemistry.

[61]  P. Schuck,et al.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. , 2000, Biophysical journal.

[62]  P. Schuck.  Sedimentation analysis of noninteracting and self-associating solutes using numerical solutions to the Lamm equation. , 1998, Biophysical journal.

[63]  M. Ultsch,et al.  The X-ray structure of a growth hormone–prolactin receptor complex , 1994, Nature.

[64]  D. Soares,et al.  Complement Control Protein Modules in the Regulators of Complement Activation , 2005 .

[65]  T. Narayanan,et al.  SAXS and USAXS on the high brilliance beamline at the ESRF , 2001 .

[66]  Ami Miller,et al.  Complement Factor H Binds at Two Independent Sites to C-reactive Protein in Acute Phase Concentrations*♦ , 2009, The Journal of Biological Chemistry.

[67]  Victoria A. Higman,et al.  His-384 Allotypic Variant of Factor H Associated with Age-related Macular Degeneration Has Different Heparin Binding Properties from the Non-disease-associated Form* , 2006, Journal of Biological Chemistry.

[68]  S. Perkins,et al.  Electrostatic interactions contribute to the folded-back conformation of wild type human factor H. , 2009, Journal of molecular biology.

[69]  Bala Ramesh,et al.  Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H. , 2003, Archives of biochemistry and biophysics.

[70]  Jeffrey J. Gray,et al.  High-resolution protein-protein docking. , 2006, Current opinion in structural biology.

[71]  James L Cole,et al.  Analytical ultracentrifugation: sedimentation velocity and sedimentation equilibrium. , 2008, Methods in cell biology.

[72]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[73]  D. Bok.  Evidence for an inflammatory process in age-related macular degeneration gains new support. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[74]  W. Maret,et al.  Zinc-buffering capacity of a eukaryotic cell at physiological pZn , 2006, JBIC Journal of Biological Inorganic Chemistry.

[75]  S. Ranganathan,et al.  A common site within factor H SCR 7 responsible for binding heparin, C‐reactive protein and streptococcal M protein , 2003 .

[76]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[77]  M. Pangburn,et al.  Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[78]  S Goelz,et al.  The crystal structure of human interferon beta at 2.2-A resolution. , 1997 .

[79]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[80]  D. Uhrín,et al.  Structural basis for complement factor H–linked age-related macular degeneration , 2007, The Journal of experimental medicine.

[81]  S. Perkins,et al.  Unravelling protein-protein interactions between complement factor H and C-reactive protein using a multidisciplinary strategy. , 2010, Biochemical Society transactions.

[82]  M. Pangburn,et al.  Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement. , 2000, Immunopharmacology.

[83]  J. S. Sodhi,et al.  Predicting metal-binding site residues in low-resolution structural models. , 2004, Journal of molecular biology.

[84]  M. Walport,et al.  Complement. Second of two parts. , 2001, The New England journal of medicine.

[85]  D. Uhrín,et al.  Structure of the N-terminal Region of Complement Factor H and Conformational Implications of Disease-linked Sequence Variations*S⃞ , 2008, Journal of Biological Chemistry.

[86]  A. V. Semenyuk,et al.  GNOM – a program package for small-angle scattering data processing , 1991 .

[87]  Eric P Hoffman,et al.  Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. , 2006, Journal of proteome research.

[88]  Masaru Miyagi,et al.  Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[89]  R. Strohmeyer,et al.  Association of factor H of the alternative pathway of complement with agrin and complement receptor 3 in the Alzheimer's disease brain , 2002, Journal of Neuroimmunology.

[90]  Ami Miller,et al.  Multiple interactions of complement Factor H with its ligands in solution: a progress report. , 2010, Advances in experimental medicine and biology.

[91]  B. Moffatt,et al.  Complement factor I and cofactors in control of complement system convertase enzymes. , 1993, Methods in enzymology.

[92]  D. Auld.  Zinc coordination sphere in biochemical zinc sites , 2001, Biometals.

[93]  Ronny Blust,et al.  Toxicity, accumulation, and retention of zinc by carp under normoxic and hypoxic conditions , 2006, Environmental toxicology and chemistry.